drugset
drugset / Trial / NCT04559295

Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs

NCT04559295 ↗

Phase 2/3 Unknown 80 enrolled Stem Cures
Non-randomizedParallel-groupSingle-blindTreatment

Summary

Intradiscal delivery of bone marrow concentrate (BMC) into discs, facet, epidural space, and sacroiliac joints

Timeline

Start
2018-11-21
Primary completion
2020-03-19
Completion
2021-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Bone Marrow Concentrate Cell therapy — Other

Indications

arthropathy intervertebral disk degenerative disorder radiculopathy spinal stenosis